Meta-analysis of drug eluting stents compared with bare metal stents in high bleeding risk patients undergoing percutaneous coronary interventions-Reference-Cited by-同舟云学术

Meta-analysis of drug eluting stents compared with bare metal stents in high bleeding risk patients undergoing percutaneous coronary interventions

Published:2018-12-26 Issue:1 Volume:94 Page:98-104
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Catheter Cardiovasc Interv

Author:

Neupane Saroj¹,Khawaja Owais²,Edla Sushruth²,Singh Hemindermeet³,Othman Hussein²,Bossone Eduardo⁴,Yamasaki Hiroshi²,Rosman Howard S.²,Eggebrecht Holger⁵,Mehta Rajendra H.⁶

Affiliation:

1. Division of Cardiology, Department of Internal Medicine; Henry Ford Hospital; Detroit Michigan

2. Division of Cardiology, Department of Internal Medicine; St John Hospital and Medical Center; Detroit Michigan

3. Cardiovascular Fellowship Program; Mercy-Health St Vincent Medical Center; Toledo Ohio

4. Cava de' Tirreni and Amalfi Coast Hospital; University of Salerno; Amalfi Italy

5. Cardioangiological Center Bethanien (CCB) and AGAPLESION Bethanien Hospital; Frankfurt Germany

6. Duke Clinical Research Institute; Durham North Carolina

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ccd.28045/fullpdf

Reference24 articles.

1. Long-term safety of drug-eluting and bare-metal stents: Evidence from a comprehensive network meta-analysis;Palmerini;J Am Coll Cardiol,2015

2. Drug-eluting or bare-metal stents for coronary artery disease;Bønaa;N Engl J Med,2016

3. A prospective randomized trial of everolimus-eluting stents versus bare-metal stents in octogenarians: The XIMA trial (Xience or vision stents for the Management of Angina in the elderly);De Belder;J Am Coll Cardiol,2014

4. Risk of stent thrombosis among bare-metal stents, first-generation drug-eluting stents, and second-generation drug-eluting stents: Results from a registry of 18,334 patients;Tada;JACC Cardiovasc Interv,2013

5. Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial;Sabaté;Lancet,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coronary Revascularization in Patients With Cancer;Current Treatment Options in Cardiovascular Medicine;2023-04-21

2. Percutaneous coronary intervention in patients with cancer using bare metal stents compared to drug-eluting stents;Frontiers in Cardiovascular Medicine;2022-10-19

3. Impact of Stent Types on In-Hospital Outcomes of Patients With Cancer Undergoing Percutaneous Coronary Intervention: A Nationwide Analysis;Cardiovascular Revascularization Medicine;2022-09

4. First-in-Man Evaluation of a Sirolimus-Eluting Stent With Abluminal Fluoropolymeric/Triflusal Coating With Ultrathin Struts by OCT at 9 Months' Follow-Up: The PROMETHEUS Study;Cardiovascular Revascularization Medicine;2021-11

5. Comparison of One-Year Outcomes Between the ihtDEStiny BD Stent and the Durable-Polymer Everolimus- and Zotarolimus-Eluting Stents: A Propensity-Score-Matched Analysis;Cardiovascular Revascularization Medicine;2021-10